Aaron, with strong partnerships with internal and external stakeholders manages an extensive portfolio of Life Science technologies including therapeutics, diagnostics, research tools & reagents, and healthcare IT. He leverages his passion for understanding innovation and building relations to help guide commercialization strategy and accelerate Utah intellectual property to licensing and the market. Aaron received a PhD in Biochemistry and Molecular Genetics from the University of Alabama at Birmingham, an MS in Biochemistry from Brigham Young University, and a BS in Biology from Brigham Young University-Hawaii.